Clopiswift Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Clopidogrel

Indications/Uses

Patients w/ moderate to high-risk transient ischemic attack (TIA) or minor ischemic stroke (IS). Prevention of atherothrombotic & thromboembolic events in atrial fibrillation. Secondary prevention of atherothrombotic events.

Dosage/Direction for Use

Adult & elderly 75 mg as single daily dose. Non-ST segment elevation acute coronary syndrome Loading dose: 300 or 600 mg. Patient <75 yr when percutaneous coronary intervention is intended Loading dose: 600 mg. ST segment elevation acute MI 75 mg as single daily dose w/ 300 mg loading dose in combination w/ ASA & w/ or w/o thrombolytics. Moderate to high-risk TIA or minor IS Adult Loading dose: 300 mg followed by 75 mg once daily & ASA 75-100 mg once daily. Start treatment w/ clopidogrel & ASA w/in 24 hr of event & continue for 21 days followed by single antiplatelet therapy. Patient w/ atrial fibrillation 75 mg as single daily dose. Initiate ASA 75-100 mg daily & continue in combination w/ clopidogrel.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity. Active pathological bleeding (eg, peptic ulcer or intracranial hemorrhage). Severe hepatic impairment.

MIMS Class

Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)

ATC Classification

B01AC04 - clopidogrel ; Belongs to the class of platelet aggregation inhibitors excluding heparin. Used in the treatment of thrombosis.

Regulatory Classification

POM

Presentation/Packing

Form

Clopiswift FC tab 75 mg

Packing/Price

1's

Clopiswift

clopidogrel

Manufacturer:

Ind-Swift